A new Periodic Transaction Report filed with the U.S. House of Representatives shows that Hon. Richard Dean Dr McCormick sold shares of Johnson & Johnson Common Stock (JNJ) on July 30, 2026. The transaction, valued at between $1,001 and $15,000, was executed by the member of Congress personally and held through a Growth Partners Roth IRA account. Under the STOCK Act, members of Congress and their staff are required to disclose trades like this one within 45 days, giving the public a window into the personal portfolios of lawmakers who help shape policy affecting publicly traded companies.
This filing is classified on WhoIsBuyingNow.com as a straightforward congress sale — a disclosed disposal of stock rather than a purchase or a more complex option-related transaction. The relatively small dollar range disclosed is typical of many congressional trades, which are reported in bands rather than exact figures.
A Notable Overlap With Insider Activity
What makes this filing worth flagging is its timing relative to activity inside Johnson & Johnson itself. Company insider Duato Joaquin also sold JNJ shares on August 5, 2026, in a transaction worth $10,827,256 — a sale that landed within 30 days of Rep. McCormick’s own disclosed transaction. While there is no indication these two sales are connected, and STOCK Act disclosure is a legal reporting obligation rather than any suggestion of wrongdoing, the proximity of a congressional sale and a large insider sale in the same stock within a short window is exactly the kind of pattern this site exists to surface for readers doing their own research.
It’s worth noting that insider sales by corporate executives and disclosures by members of Congress originate from very different reporting regimes — Form 4 filings with the SEC in the case of company insiders, and Periodic Transaction Reports with the House or Senate for lawmakers. Seeing both types of signals cluster around the same ticker in a short timeframe doesn’t establish any relationship between the two parties, but it does add context to how JNJ shares were changing hands during this period.
Readers who track institutional and fund-level portfolio activity alongside individual disclosures like this one may also be interested in our ongoing coverage of large asset managers’ quarterly filings, including MILFORD FUNDS LTD: 13F Portfolio Moves Tracked Quarterly, which tracks how institutional holders adjust their positions over time.
As with all disclosures covered here, this report reflects a legally required filing and is presented for informational purposes only. It is not a recommendation to buy, sell, or hold any security.